These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 16190790

  • 1. Elevated thyroid indices in children and adolescents with obsessive-compulsive disorder: effects of clomipramine treatment.
    McCracken JT, Hanna GL.
    J Child Adolesc Psychopharmacol; 2005 Aug; 15(4):581-7. PubMed ID: 16190790
    [Abstract] [Full Text] [Related]

  • 2. Prolactin in childhood obsessive-compulsive disorder: clinical correlates and response to clomipramine.
    Hanna GL, McCracken JT, Cantwell DP.
    J Am Acad Child Adolesc Psychiatry; 1991 Mar; 30(2):173-8. PubMed ID: 2016218
    [Abstract] [Full Text] [Related]

  • 3. A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.
    Milanfranchi A, Ravagli S, Lensi P, Marazziti D, Cassano GB.
    Int Clin Psychopharmacol; 1997 May; 12(3):131-6. PubMed ID: 9248868
    [Abstract] [Full Text] [Related]

  • 4. A controlled comparison of adjuvant lithium carbonate or thyroid hormone in clomipramine-treated patients with obsessive-compulsive disorder.
    Pigott TA, Pato MT, L'Heureux F, Hill JL, Grover GN, Bernstein SE, Murphy DL.
    J Clin Psychopharmacol; 1991 Aug; 11(4):242-8. PubMed ID: 1918422
    [Abstract] [Full Text] [Related]

  • 5. Clinical features associated with treatment response in obsessive-compulsive disorder.
    Shavitt RG, Belotto C, Curi M, Hounie AG, Rosário-Campos MC, Diniz JB, Ferrão YA, Pato MT, Miguel EC.
    Compr Psychiatry; 2006 Aug; 47(4):276-81. PubMed ID: 16769302
    [Abstract] [Full Text] [Related]

  • 6. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.
    Foa EB, Liebowitz MR, Kozak MJ, Davies S, Campeas R, Franklin ME, Huppert JD, Kjernisted K, Rowan V, Schmidt AB, Simpson HB, Tu X.
    Am J Psychiatry; 2005 Jan; 162(1):151-61. PubMed ID: 15625214
    [Abstract] [Full Text] [Related]

  • 7. Convergent and discriminant validity of the Children's Yale-Brown Obsessive Compulsive Scale-Symptom Checklist.
    Gallant J, Storch EA, Merlo LJ, Ricketts ED, Geffken GR, Goodman WK, Murphy TK.
    J Anxiety Disord; 2008 Dec; 22(8):1369-76. PubMed ID: 18329843
    [Abstract] [Full Text] [Related]

  • 8. Clomipramine and obsessive-compulsive disorder.
    Scahill L, Lynch KA.
    J Child Adolesc Psychiatr Nurs; 1995 Dec; 8(2):42-5. PubMed ID: 7795952
    [Abstract] [Full Text] [Related]

  • 9. Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorder.
    Hewlett WA, Vinogradov S, Agras WS.
    J Clin Psychopharmacol; 1992 Dec; 12(6):420-30. PubMed ID: 1474179
    [Abstract] [Full Text] [Related]

  • 10. Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study.
    Flament MF, Rapoport JL, Berg CJ, Sceery W, Kilts C, Mellström B, Linnoila M.
    Arch Gen Psychiatry; 1985 Oct; 42(10):977-83. PubMed ID: 3899048
    [Abstract] [Full Text] [Related]

  • 11. Symptoms and physiologic manifestations in obsessive compulsive patients before and after treatment with clomipramine.
    Hoehn-Saric R, McLeod DR, Zimmerli WD, Hipsley PA.
    J Clin Psychiatry; 1993 Jul; 54(7):272-6. PubMed ID: 8335655
    [Abstract] [Full Text] [Related]

  • 12. Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder--a multicenter trial.
    DeVeaugh-Geiss J, Moroz G, Biederman J, Cantwell D, Fontaine R, Greist JH, Reichler R, Katz R, Landau P.
    J Am Acad Child Adolesc Psychiatry; 1992 Jan; 31(1):45-9. PubMed ID: 1537780
    [Abstract] [Full Text] [Related]

  • 13. Clinical predictors of treatment response in obsessive compulsive disorder: exploratory analyses from multicenter trials of clomipramine.
    DeVeaugh-Geiss J, Katz R, Landau P, Goodman W, Rasmussen S.
    Psychopharmacol Bull; 1990 Jan; 26(1):54-9. PubMed ID: 2196627
    [Abstract] [Full Text] [Related]

  • 14. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP, Trimble MR, Deakin JF, Stokes TM, Ashford JJ.
    J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the effects of clomipramine on canine thyroid function tests.
    Gulikers KP, Panciera DL.
    J Vet Intern Med; 2003 Jul; 17(1):44-9. PubMed ID: 12564726
    [Abstract] [Full Text] [Related]

  • 16. Predictive value of obsessive-compulsive personality disorder in antiobsessional pharmacological treatment.
    Cavedini P, Erzegovesi S, Ronchi P, Bellodi L.
    Eur Neuropsychopharmacol; 1997 Feb; 7(1):45-9. PubMed ID: 9088884
    [Abstract] [Full Text] [Related]

  • 17. Multicentre, double-blind, comparison of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.
    Mundo E, Maina G, Uslenghi C.
    Int Clin Psychopharmacol; 2000 Mar; 15(2):69-76. PubMed ID: 10759337
    [Abstract] [Full Text] [Related]

  • 18. Successful augmentation with aripiprazole in clomipramine-refractory obsessive-compulsive disorder.
    da Rocha FF, Correa H.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct 01; 31(7):1550-1. PubMed ID: 17692447
    [No Abstract] [Full Text] [Related]

  • 19. Thyroid hormone concentrations in depressed and nondepressed adolescents: group differences and behavioral relations.
    Dorn LD, Burgess ES, Dichek HL, Putnam FW, Chrousos GP, Gold PW.
    J Am Acad Child Adolesc Psychiatry; 1996 Mar 01; 35(3):299-306. PubMed ID: 8714317
    [Abstract] [Full Text] [Related]

  • 20. Pharmacotherapy of obsessive-compulsive disorder.
    Klein DF.
    Encephale; 1990 Mar 01; 16 Spec No():331-4. PubMed ID: 2209491
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.